WisdomTree BioRevolution Fund Rating $14.98 +0.66 (+4.62%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.74Holdings in WDNA have an aggregate rating of Moderate Buy based on 704 analyst ratings issued in the past year covering 46 companies (70.8% of the portfolio).WDNA Aggregate Price Target$14.98High Prediction$14.98Average Prediction$14.98Low Prediction$14.98Holdings in WDNA have an aggregate price target of $14.98 and a range of $14.98 to $14.98 covering 46 companies (70.8% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.24%NTRANatera$172.48+3.0%2.383 of 5 stars3.00$160.63 -6.9%16Gap Up3.44%TWSTTwist Bioscience$52.23+3.5%2.8846 of 5 stars2.70$51.90 -0.6%102.92%VCELVericel$58.95-1.0%1.8727 of 5 stars3.00$62.14 5.4%72.88%BPMCBlueprint Medicines$112.39+0.4%1.111 of 5 stars2.65$122.72 9.2%202.62%VCYTVeracyte$43.78+0.4%3.9682 of 5 stars2.67$41.13 -6.1%9News Coverage2.40%BBIOBridgeBio Pharma$35.61-1.3%4.0911 of 5 stars2.86$48.08 35.0%142.35%LLYEli Lilly and Company$756.54+1.9%4.9942 of 5 stars2.81$1,002.22 32.5%21Analyst Revision1.92%AGIOAgios Pharmaceuticals$33.54+0.9%3.8249 of 5 stars2.50$56.33 68.0%8Short Interest ↑1.86%GERNGeron$2.98+0.6%3.7274 of 5 stars3.09$7.25 143.4%111.85%UTHRUnited Therapeutics$371.72+1.0%4.9282 of 5 stars2.73$378.36 1.8%15Positive News1.63%ALNYAlnylam Pharmaceuticals$267.76+1.0%4.456 of 5 stars2.72$298.61 11.5%25Analyst Forecast1.57%SRPTSarepta Therapeutics$116.18-0.5%4.964 of 5 stars2.91$178.71 53.8%22Analyst Revision1.47%DHRDanaher$245.76+0.7%4.8805 of 5 stars2.75$285.55 16.2%20Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoveragePositive News1.46%VRTXVertex Pharmaceuticals$428.35+0.1%4.3026 of 5 stars2.52$490.38 14.5%31Positive News1.40%RAREUltragenyx Pharmaceutical$42.81+3.7%4.6112 of 5 stars2.93$92.29 115.6%14Analyst Revision1.38%GILDGilead Sciences$92.23-0.8%4.5644 of 5 stars2.70$97.96 6.2%27Analyst RevisionPositive News1.34%DDDuPont de Nemours$78.39-0.1%4.9078 of 5 stars2.75$98.00 25.0%12Analyst Upgrade1.33%LHLaboratory Co. of America$242.48-0.6%4.8531 of 5 stars2.88$260.54 7.4%16Positive News1.32%AMGNAmgen$273.18-0.6%4.8885 of 5 stars2.44$314.91 15.3%27Analyst RevisionPositive News1.31%BMYBristol-Myers Squibb$56.58-0.8%4.9166 of 5 stars2.29$56.27 -0.5%21Analyst RevisionPositive News1.31%QGENQiagen$47.70+0.4%3.5883 of 5 stars2.56$51.50 8.0%91.30%CTVACorteva$63.00-0.2%4.6942 of 5 stars2.68$65.59 4.1%19Analyst ForecastNews CoveragePositive News1.28%FOLDAmicus Therapeutics$9.54+0.3%4.4226 of 5 stars2.78$16.88 76.9%9Analyst RevisionGap Up1.28%TMOThermo Fisher Scientific$578.13+0.9%4.9777 of 5 stars2.86$648.95 12.3%22News CoveragePositive News1.27%IOVAIovance Biotherapeutics$5.92+0.6%4.1519 of 5 stars2.88$23.00 288.8%81.25%RGENRepligen$168.89+0.6%3.0576 of 5 stars2.62$185.20 9.7%131.24%BEAMBeam Therapeutics$24.69+0.7%3.5098 of 5 stars2.92$47.67 93.1%121.24%BNTXBioNTech$115.67-1.4%2.7103 of 5 stars2.88$142.72 23.4%171.23%TSNTyson Foods$55.70-1.3%4.9136 of 5 stars1.90$60.70 9.0%10Analyst Forecast1.22%ZTSZoetis$167.27-0.2%4.8733 of 5 stars3.09$211.89 26.7%11Positive News1.19%DARDarling Ingredients$34.82-1.7%4.0387 of 5 stars2.78$53.44 53.5%91.17%ILMNIllumina$143.07+1.2%4.5229 of 5 stars2.70$165.63 15.8%20Analyst Revision1.16%TECHBio-Techne$78.81+0.1%3.9287 of 5 stars2.63$82.00 4.1%8News Coverage1.16%JNJJohnson & Johnson$142.96-3.5%4.9885 of 5 stars2.43$173.27 21.2%14Earnings ReportAnalyst ForecastOptions VolumeNews CoveragePositive News1.15%MRKMerck & Co., Inc.$96.66+0.4%4.9993 of 5 stars2.67$123.00 27.2%21Analyst ForecastAnalyst RevisionNews CoveragePositive News1.14%IONSIonis Pharmaceuticals$32.47-0.6%4.2283 of 5 stars2.68$60.65 86.8%191.13%EXASExact Sciences$54.20-0.1%4.8216 of 5 stars2.94$72.94 34.6%18Analyst RevisionNews Coverage1.12%REGNRegeneron Pharmaceuticals$689.30+0.2%4.6187 of 5 stars2.65$1,015.38 47.3%23Analyst RevisionNews Coverage1.11%AZNAstraZeneca$68.20+0.3%3.826 of 5 stars3.00$89.75 31.6%10Analyst Revision1.09%NEONeoGenomics$14.41+1.6%3.1142 of 5 stars2.82$20.30 40.9%111.05%ARCTArcturus Therapeutics$17.69+7.8%2.495 of 5 stars3.14$66.75 277.4%7Short Interest ↑Positive News1.03%BIOBio-Rad Laboratories$353.92+0.0%4.1082 of 5 stars2.60$394.20 11.4%5Positive News1.02%CRSPCRISPR Therapeutics$42.12+1.5%2.4917 of 5 stars2.47$78.38 86.1%19Short Interest ↑Analyst Revision1.00%MYGNMyriad Genetics$12.50-0.6%4.066 of 5 stars2.00$23.92 91.3%130.99%ARGXargenx$644.37-0.5%2.3274 of 5 stars2.86$658.39 2.2%220.97%GMABGenmab A/S$21.02-3.6%4.502 of 5 stars2.67$45.20 115.0%9 This page (BATS:WDNA) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget 99.999% of Stocks… Do This insteadThis might sound crazy to say... But FORGET most stocks. Because I have a different strategy... One t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
